膀胱内化疗的风险适应性应用。 - Suppr

Suppr

超能文献

Risk-adapted use of intravesical chemotherapy.

作者信息

Lerner Seth P, Au Jessie L-S

机构信息

Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

BJU Int. 2008 Nov;102(9 Pt B):1247-53. doi: 10.1111/j.1464-410X.2008.07967.x.

DOI:10.1111/j.1464-410X.2008.07967.x

PMID:19035889

Abstract

摘要

相似文献

Risk-adapted use of intravesical chemotherapy.

BJU Int. 2008 Nov;102(9 Pt B):1247-53. doi: 10.1111/j.1464-410X.2008.07967.x.

Intravesical chemotherapy.

Prog Clin Biol Res. 1984;162B:125-50.

Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.

Am J Clin Oncol. 2003 Aug;26(4):402-7. doi: 10.1097/01.COC.0000026911.98171.C6.

Risk-adapted use of intravesical immunotherapy.

BJU Int. 2008 Nov;102(9 Pt B):1254-64. doi: 10.1111/j.1464-410X.2008.07968.x.

Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.

Eur Urol. 2007 Oct;52(4):1129-30. doi: 10.1016/j.eururo.2007.02.064.

Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.

Eur Urol. 2007 Oct;52(4):1123-29. doi: 10.1016/j.eururo.2007.02.063. Epub 2007 Mar 12.

Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?

Urology. 2010 Oct;76(4):794-6. doi: 10.1016/j.urology.2010.04.069.

BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.

Prog Clin Biol Res. 1992;378:55-7.

Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder.

J Urol. 1995 May;153(5):1444-50.

[Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].

Aktuelle Urol. 2009 Sep;40(5):307-9. doi: 10.1055/s-0029-1224551. Epub 2009 Jul 27.

引用本文的文献

Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.

J Urol. 2015 Jul;194(1):230-7. doi: 10.1016/j.juro.2015.02.036. Epub 2015 Feb 11.

Recent advances in the diagnosis and treatment of bladder cancer.

BMC Med. 2013 Jan 17;11:13. doi: 10.1186/1741-7015-11-13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Risk-adapted use of intravesical chemotherapy.

作者信息

Lerner Seth P, Au Jessie L-S

机构信息

Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

BJU Int. 2008 Nov;102(9 Pt B):1247-53. doi: 10.1111/j.1464-410X.2008.07967.x.

DOI:10.1111/j.1464-410X.2008.07967.x

PMID:19035889

Abstract

摘要